EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Supraceliac aorta as antegrade inflow for chronic mesenteric ischemia is a viable option in high-surgical-risk patients

Georges Ghorayeb, Didier Plissonnier

Vascular Diseases · 2026

DOI: 10.1016/j.vasdi.2026.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Diseases, 2026. Verfasst von Georges Ghorayeb und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Rouen University Hospital, 1, rue de Germont, 76031 Rouen Cedex, France. Electronic address: georges.ghorayeb@chu-rou…. Hauptthemen laut MEDLINE: Mesenteric Ischemia, Mesenteric Vascular Occlusion, Blood Vessel Prosthesis Implantation, Mesenteric Artery, Superior. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the feasibility and early outcomes of antegrade visceral revascularization using the supraceliac aorta as inflow in high-surgical-risk patients with chronic mesenteric ischemia (CMI) refractory to endovascular treatment. PATIENTS AND METHODS: A retrospective review was conducted from 2015 to 2022 including patients who underwent supraceliac to visceral bypass for symptomatic CMI after failed endovascular revascularization. All patients were deemed high risk based on the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) score. Bypasses were performed through a transperitoneal midline approach using partial aortic cross-clamping. The primary outcome was 30-day mortality. Secondary outcomes included postoperative complications, intensive care unit (ICU) stay, and long-term survival. RESULTS: Twelve patients (median age 75 years; 6 women) underwent surgery. Bypasses targeted the superior mesenteric artery alone (n=10) or combined with the common hepatic artery (n=2), using prosthetic (n=12) or venous grafts (n=2). Median aortic clamping time was 24minutes. In this series there was no 30-day mortality. Postoperative complications were limited to one case of pneumonia and one transient acute kidney injury. Median ICU stay was 2 days. All patients experienced symptom resolution. At a median follow-up of 45 months, 11 of 12 patients were alive. CONCLUSION: Antegrade revascularization from the supraceliac aorta via midline laparotomy is feasible in selected high-surgical-risk patients with CMI. This approach could be considered when endovascular options fail.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenteric IschemiaMesenteric Vascular OcclusionBlood Vessel Prosthesis ImplantationMesenteric Artery, SuperiorHumansFemaleRetrospective StudiesMaleChronic DiseaseTreatment OutcomeAgedRisk FactorsFeasibility StudiesPostoperative ComplicationsTime FactorsAged, 80 and overRisk AssessmentMiddle AgedSplanchnic Circulation

Stichwörter der Autor:innen

Antegrade bypassChronic mesenteric ischemiaHigh-risk patientsOpen revascularizationSupraceliac aorta

Autor:innen und Institutionen

  • Department of Vascular Surgery, Rouen University Hospital, 1, rue de Germont, 76031 Rouen Cedex, France. Electronic address: georges.ghorayeb@chu-rouen.fr.
  • Department of Vascular Surgery, Rouen University Hospital, 1, rue de Germont, 76031 Rouen Cedex, France. Electronic address: didier.plissonnier@chu-rouen.fr.

Zitieren

APA

Ghorayeb, G., & Plissonnier, D. (2026). Supraceliac aorta as antegrade inflow for chronic mesenteric ischemia is a viable option in high-surgical-risk patients. Vascular Diseases. https://doi.org/10.1016/j.vasdi.2026.02.005

Vancouver

Ghorayeb G, Plissonnier D. Supraceliac aorta as antegrade inflow for chronic mesenteric ischemia is a viable option in high-surgical-risk patients. Vascular Diseases. 2026. doi:10.1016/j.vasdi.2026.02.005

BibTeX
@article{Ghorayeb2026,
  author = {Ghorayeb, Georges and Plissonnier, Didier},
  title = {Supraceliac aorta as antegrade inflow for chronic mesenteric ischemia is a viable option in high-surgical-risk patients},
  journal = {Vascular Diseases},
  year = {2026},
  doi = {10.1016/j.vasdi.2026.02.005}
}
Kostenlos starten →